US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
AVXL holding history
Anavex Life Sciences Corp. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,000
- Value
- $12.9K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,000 | $12.9K | <0.1% | −670−11.8% | Reduced | Holders |
| Q1 2026 | 5,670 | $17.4K | <0.1% | +670+13.4% | Added | Holders |
| Q4 2025 | 5,000 | $17.8K | <0.1% | −479−8.7% | Reduced | Holders |
| Q3 2025 | 5,479 | $48.8K | <0.1% | −733−11.8% | Reduced | Holders |
| Q2 2025 | 6,212 | $57.3K | <0.1% | +687+12.4% | Added | Holders |
| Q1 2025 | 5,525 | $47.4K | <0.1% | −147−2.6% | Reduced | Holders |
| Q4 2024 | 5,672 | $60.9K | <0.1% | +29+0.5% | Added | Holders |
| Q3 2024 | 5,643 | $32.1K | <0.1% | +479+9.3% | Added | Holders |
| Q2 2024 | 5,164 | $21.8K | <0.1% | −311−5.7% | Reduced | Holders |
| Q1 2024 | 5,475 | $27.9K | <0.1% | +52+1.0% | Added | Holders |
| Q4 2023 | 5,423 | $50.5K | <0.1% | +259+5.0% | Added | Holders |
| Q3 2023 | 5,164 | $33.8K | <0.1% | +4,907+1,909.3% | Added | Holders |
| Q2 2023 | 257 | $2.09K | <0.1% | −607−70.3% | Reduced | Holders |
| Q1 2023 | 864 | $7.40K | <0.1% | +658+319.4% | Added | Holders |
| Q4 2022 | 206 | $1.91K | <0.1% | +42+25.6% | Added | Holders |
| Q3 2022 | 164 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 164 | $2.00K | <0.1% | +164 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −505−100.0% | Sold out | Holders |
| Q4 2021 | 505 | $9.00K | <0.1% | +478+1,770.4% | Added | Holders |
| Q3 2021 | 27 | $0 | 0.0% | +27 | New | Holders |